{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:09:28Z","timestamp":1791526168036,"version":"4.3.4"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Liver failure (LF) is a serious liver function damage caused by various factors, mainly jaundice, hepatic encephalopathy, coagulation disorders and multiple organ failure, with the clinical characteristic of high short-term mortality. LF is often accompanied by excessive activation of inflammatory factors, and an excessive systemic inflammatory response (i.e., inflammatory storm) is considered to be the trigger of LF. However, a specific prognostic model including inflammatory factors for patients with LF has not been well established.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To establish and validate a nomogram for predicting 28-day, 90-day, and 180-day mortality in patients with LF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 423 eligible LF patients were enrolled in this retrospective study. Independent predictors were identified using a multivariate logistic model and then integrated into a nomogram to predict 28-day, 90-day, and 180-day mortality. The concordance index, receiver operating characteristic curves, and calibration plots were used to evaluate the performance of the model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sex, age, total bilirubin, aspartate aminotransferase, international normalized ratio, Child\u2013Pugh score, and serum interleukin-6 were independent risk factors for death at 28, 90, and 180 days in LF patients. The nomogram showed good calibration and discrimination with an area under the receiver operating characteristic curve (AUC) of 0.927. The calibration curve fit as well, indicating that the nomogram had good clinical application value.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This nomogram model for predicting the 28-day, 90-day, and 180-day mortality of LF patients could help optimize treatment strategies and improve prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1035699","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T06:37:15Z","timestamp":1668580635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["A practical nomogram based on serum interleukin-6 for the prognosis of liver failure"],"prefix":"10.3389","volume":"9","author":[{"given":"Nanxi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","article-title":"Acute liver failure.","volume":"394","author":"Stravitz","year":"2019","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2021.06.018","article-title":"Towards a new definition of decompensated cirrhosis.","volume":"76","author":"D\u2019Amico","year":"2021","journal-title":"J Hepatol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis.","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure.","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/hep.29581","article-title":"Cell death markers in patients with cirrhosis and acute decompensation.","volume":"67","author":"Macdonald","year":"2018","journal-title":"Hepatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cyto.2016.12.017","article-title":"From stable disease to acute-on-chronic liver failure: circulating cytokines are related to prognosis in different stages of cirrhosis.","volume":"91","author":"Fischer","year":"2017","journal-title":"Cytokine."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i30.4479","article-title":"High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure.","volume":"26","author":"Zhou","year":"2020","journal-title":"World J Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jgh3.12516","article-title":"Cystatin C and interleukin-6 for prognosticating patients with acute decompensation of cirrhosis.","volume":"5","author":"Padia","year":"2021","journal-title":"JGH Open."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/apt.15515","article-title":"Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy.","volume":"50","author":"Labenz","year":"2019","journal-title":"Aliment Pharmacol Therapeut."},{"key":"B10","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.cgh.2017.09.017","article-title":"Increased level of interleukin 6 associates with increased 90-day and 1-year mortality in patients with end-stage liver disease.","volume":"16","author":"Remmler","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","article-title":"Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure.","volume":"67","author":"Wu","year":"2018","journal-title":"Gut."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","article-title":"Toward an improved definition of acute-on-chronic liver failure.","volume":"147","author":"Jalan","year":"2014","journal-title":"Gastroenterology."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122158","article-title":"Comparison of current diagnostic criteria for acute-on-chronic liver failure.","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One."},{"key":"B14","first-page":"18","article-title":"Guideline for diagnosis and treatment of liver failure.","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases.","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/lt.21050","article-title":"Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King\u2019s College Hospital criteria.","volume":"13","author":"Dhiman","year":"2007","journal-title":"Liver Transpl."},{"key":"B17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","article-title":"Acute-on-chronic liver failure: terminology, mechanisms and management.","volume":"13","author":"Sarin","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122632","article-title":"Leukocytes, systemic inflammation and immunopathology in acute-on-chronic liver failure.","volume":"9","author":"Casulleras","year":"2020","journal-title":"Cells."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000941","article-title":"The relationship between serum interleukin-6 and the recurrence of hepatitis B virus related hepatocellular carcinoma after curative resection.","volume":"94","author":"Sheng","year":"2015","journal-title":"Medicine."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184084","article-title":"Interleukin-1\u03b1 and Interleukin-1\u03b2 play a central role in the pathogenesis of fulminant hepatic failure in mice.","volume":"12","author":"Sultan","year":"2017","journal-title":"PLoS One."},{"key":"B21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.14218\/JCTH.2020.00157","article-title":"UMSCs attenuate LPS\/D-GalN-induced acute liver failure in mice by down-regulating the MyD88\/NF-\u03baB pathway.","volume":"9","author":"Liao","year":"2021","journal-title":"J Clin Transl Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1111\/liv.12428","article-title":"Cardiac and proinflammatory markers predict prognosis in cirrhosis.","volume":"34","author":"Wiese","year":"2014","journal-title":"Liver Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2015.10.006","article-title":"Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity.","volume":"77","author":"Dirchwolf","year":"2016","journal-title":"Cytokine."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5545181","article-title":"Plasma interleukin-6 level: a potential prognostic indicator of emergent HBV-associated ACLF.","volume":"2021","author":"Wu","year":"2021","journal-title":"Can J Gastroenterol Hepatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1035699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T06:37:18Z","timestamp":1668580638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1035699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":24,"alternative-id":["10.3389\/fmed.2022.1035699"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1035699","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"article-number":"1035699"}}